A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors

NCT06452160 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Mesothelioma
Epithelioid Hemangioendothelioma(EHE)
Solid Tumor

Interventions

DRUG: BGC515

Sponsor

BridGene Biosciences Inc.